RxDoctor Payments Data

Vivian Hunt, APRN

Family · Ashland, KYNPI 1073109948

Payments from drug & device makers

$9,262in general payments, 2019–2025

Across 100 payments — averaging $92.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • E.r. Squibb & Sons, L.L.C.$3K
  • LEO Pharma Inc.$845
  • Johnson & Johnson$656
  • Sanofi$329
  • Arcutis Biotherapeutics, Inc.$307
  • plus $778 from 16 others

What the payments were for

  • Consulting fees$5,59260%
  • Food & beverage$3,50638%
  • Education$1642%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,262 in reported general payments places this provider in the 95th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$66,611
Medicare patients
471
Services billed
2,247

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa19$373,893
OtezlaApremilast56$290,915
Humira(Cf) PenAdalimumab12$115,765
SotyktuDeucravacitinib18$115,637
Dupixent PenDupilumab11$38,391
Fluorouracil86$6,929
Clobetasol Propionate57$2,780
Clindamycin Phosphate46$2,109
Ketoconazole85$2,106
Imiquimod86$1,708
Metronidazole13$1,145
Doxycycline Monohydrate44$1,140
Halobetasol Propionate24$915
Triamcinolone Acetonide98$620
Betamethasone Dipropionate19$603

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla$188$290,91556 claims
E.r. Squibb & Sons, L.L.C.Sotyktu$2,852$115,63718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,374 family providers in Kentucky.

Other family in Ashland

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →